Use of saliva and capillary blood samples as substitutes for venous blood sampling in pharmacokinetic investigations of artemisinin

Abstract.

Objectives: Artemisinin concentrations in venous plasma, capillary plasma and saliva were compared. Methods: Eighteen Vietnamese adults with uncomplicated falciparum malaria were treated with artemisinin. Saliva, capillary and venous plasma were sampled and analysed for artemisinin using high-performance liquid chromatography with an ultraviolet detector (HPLC-UV). Results: Artemisinin capillary plasma concentrations were highly correlated to its venous plasma levels (correlation coefficient r=0.92). Capillary/venous concentration ratios were significantly higher than unity at 30 min and 60 min after drug intake, indicating an arterial–venous concentration difference. Artemisinin unbound fraction in plasma averaged 0.14 (SD=0.03) and was independent of drug concentration (114–1001 ng/ml). Artemisinin concentrations in saliva were comparable to its unbound levels in plasma. Saliva levels were more highly correlated to unbound capillary plasma (r=0.85) than to unbound venous plasma concentrations (r=0.77). No statistically significant differences were found between the saliva, unbound venous and unbound capillary area under the curve (AUC) values. Conclusions: Capillary plasma or saliva may replace venous plasma in pharmacokinetic investigations of artemisinin. Due to the ease of collection and handling, saliva sampling can be a simple approach in field studies of artemisinin, although the lower saliva concentrations require more sensitive analytical methods.